Compare TRIB & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIB | VBIX |
|---|---|---|
| Founded | 1992 | N/A |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 21.0M |
| IPO Year | N/A | N/A |
| Metric | TRIB | VBIX |
|---|---|---|
| Price | $0.98 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 83.5K | 35.7K |
| Earning Date | 03-23-2026 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $61,555,000.00 | $11,056,000.00 |
| Revenue This Year | $13.51 | N/A |
| Revenue Next Year | $13.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.31 | N/A |
| 52 Week Low | $0.48 | $1.38 |
| 52 Week High | $3.44 | $9.80 |
| Indicator | TRIB | VBIX |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 33.71 |
| Support Level | $1.04 | $1.42 |
| Resistance Level | $1.22 | $1.69 |
| Average True Range (ATR) | 0.11 | 0.17 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 23.48 | 15.43 |
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.